Bulk Manufacturer of Controlled Substances Application: Halo Pharmaceutical, Inc., 63141 [2020-22076]
Download as PDF
<![CDATA[
63141
Federal Register / Vol. 85, No. 194 / Tuesday, October 6, 2020 / Notices
Issued: October 1, 2020.
Lisa Barton,
Secretary to the Commission.
In
accordance with 21 CFR 1301.33(a), this
is notice that on September 3, 2020,
Halo Pharmaceutical Inc, 30 North
Jefferson Road, Whippany, New Jersey
07981, applied to be registered as a bulk
manufacturer of the following basic
class(es) of controlled substance(s):
SUPPLEMENTARY INFORMATION:
[FR Doc. 2020–22027 Filed 10–5–20; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Controlled
substances
Drug Enforcement Administration
Drug
codes
Schedule
[Docket No. DEA–727]
Dihydromorphine ......
Hydromorphone ........
Bulk Manufacturer of Controlled
Substances Application: Halo
Pharmaceutical, Inc.
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Halo Pharmaceutical, Inc. has
applied to be registered as a bulk
manufacturer of basic class(es) of
controlled substance(s). Refer to
Supplemental Information listed below
for further drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before December 7, 2020. Such
persons may also file a written request
for a hearing on the application on or
before December 7, 2020.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
SUMMARY:
9145
9150
I
II
The company plans to manufacture
Hydromorphone (9150) for distribution
to its customers. Dihydromorphine
(9145) is an intermediate in the
manufacture of Hydromorphone and is
not for commercial distribution. No
other activity for these drug codes is
authorized for this registration.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020–22076 Filed 10–5–20; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–726]
ACTION:
Notice of application.
S&B Pharma, LLC has applied
to be registered as a bulk manufacturer
of basic class(es) of controlled
substance(s). Refer to Supplemental
Information listed below for further
drug information.
SUMMARY:
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before December 7, 2020. Such
persons may also file a written request
for a hearing on the application on or
before December 7, 2020.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
ADDRESSES:
In
accordance with 21 CFR 1301.33(a), this
is notice that on August 25, 2020, S&B
Pharma, LLC, 405 South Motor Avenue,
Azusa, California 91702, applied to be
registered as an bulk manufacturer of
the following basic class(es) of
controlled substance(s):
SUPPLEMENTARY INFORMATION:
Bulk Manufacturer of Controlled
Substances Application: S&B Pharma,
LLC
Drug Enforcement
Administration, Justice.
AGENCY:
Controlled substance
Drug code
khammond on DSKJM1Z7X2PROD with NOTICES
Gamma Hydroxybutyric Acid ...........................................................................................................................................
Marihuana ........................................................................................................................................................................
Tetrahydrocannabinols ....................................................................................................................................................
Amphetamine ...................................................................................................................................................................
Methamphetamine ...........................................................................................................................................................
Lisdexamfetamine ............................................................................................................................................................
Methylphenidate ..............................................................................................................................................................
Pentobarbital ....................................................................................................................................................................
4-Anilino-N-phenethyl-4-piperidine (ANPP) .....................................................................................................................
Tapentadol .......................................................................................................................................................................
Fentanyl ...........................................................................................................................................................................
The company plans to manufacture
the listed controlled substances in bulk
for use in product development and for
commercial sales to its customers. In
reference to drug code 7360 (Marihuana)
and 7370 (Tetrahydrocannabinols), the
company plans to bulk manufacture
both as synthetic substances. No other
activity for these drug codes is
authorized for this registration.
William T. McDermott,
Assistant Administrator.
2010
7360
7370
1100
1105
1205
1724
2270
8333
9780
9801
Drug Enforcement Administration
[Docket No. DEA–725]
[FR Doc. 2020–22075 Filed 10–5–20; 8:45 am]
Importer of Controlled Substances
Application: Wildlife Laboratories, LLC
BILLING CODE 4410–09–P
Drug Enforcement
Administration, Justice.
ACTION:
17:52 Oct 05, 2020
Jkt 253001
I
I
I
II
II
II
II
II
II
II
II
DEPARTMENT OF JUSTICE
AGENCY:
VerDate Sep<11>2014
Schedule
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
E:\FR\FM\06OCN1.SGM
Notice of application.
06OCN1
]]>Agencies
[Federal Register Volume 85, Number 194 (Tuesday, October 6, 2020)]
[Notices]
[Page 63141]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-22076]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-727]
Bulk Manufacturer of Controlled Substances Application: Halo
Pharmaceutical, Inc.
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Halo Pharmaceutical, Inc. has applied to be registered as a
bulk manufacturer of basic class(es) of controlled substance(s). Refer
to Supplemental Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before December 7,
2020. Such persons may also file a written request for a hearing on the
application on or before December 7, 2020.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on September 3, 2020, Halo Pharmaceutical Inc, 30 North
Jefferson Road, Whippany, New Jersey 07981, applied to be registered as
a bulk manufacturer of the following basic class(es) of controlled
substance(s):
------------------------------------------------------------------------
Drug
Controlled substances codes Schedule
------------------------------------------------------------------------
Dihydromorphine....................... 9145 I
Hydromorphone......................... 9150 II
------------------------------------------------------------------------
The company plans to manufacture Hydromorphone (9150) for
distribution to its customers. Dihydromorphine (9145) is an
intermediate in the manufacture of Hydromorphone and is not for
commercial distribution. No other activity for these drug codes is
authorized for this registration.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-22076 Filed 10-5-20; 8:45 am]
BILLING CODE 4410-09-P
